Author: "Torkko, Kathleen" - Searchworks@Jio Institute Digital Library Search Results

Your search keyword '"Torkko, Kathleen"' showing total 253 results

Start Over Author "Torkko, Kathleen"

253 results on '"Torkko, Kathleen"'

1. Change in prostate tissue gene expression following finasteride or doxazosin administration in the medical therapy for prostatic symptoms (MTOPS) study

Author: Choi, Hyo Young, Torkko, Kathleen C., Lucia, M. Scott, Mozhui, Khyobeni, Choi, Won-Young, Clark, Peter E., and Fowke, Jay H.
Published: 2024
Full Text: View/download PDF

2. MAP3K7 Loss Drives Enhanced Androgen Signaling and Independently Confers Risk of Recurrence in Prostate Cancer with Joint Loss of CHD1.

Author: Jillson, Lauren, Rider, Leah, Rodrigues, Lindsey, Romero, Lina, Karimpour-Fard, Anis, Nieto, Cera, Gillette, Claire, Torkko, Kathleen, Danis, Etienne, Smith, Elizabeth, Peehl, Donna, Lucia, M, Costello, James, Cramer, Scott, and Nolley, Rosie
Subjects: Androgens, Benzamides, Cell Cycle, Cell Line, Tumor, Cell Proliferation, DNA Helicases, DNA-Binding Proteins, Drug Resistance, Neoplasm, Gene Expression Regulation, Neoplastic, Humans, Logistic Models, MAP Kinase Kinase Kinases, Male, Neoplasm Recurrence, Local, Nitriles, Phenylthiohydantoin, Prostatic Neoplasms, RNA Interference, Receptors, Androgen, Risk Factors, Signal Transduction
Abstract: Prostate cancer genomic subtypes that stratify aggressive disease and inform treatment decisions at the primary stage are currently limited. Previously, we functionally validated an aggressive subtype present in 15% of prostate cancer characterized by dual deletion of MAP3K7 and CHD1. Recent studies in the field have focused on deletion of CHD1 and its role in androgen receptor (AR) chromatin distribution and resistance to AR-targeted therapy; however, CHD1 is rarely lost without codeletion of MAP3K7. Here, we show that in the clinically relevant context of co-loss of MAP3K7 and CHD1 there are significant, collective changes to aspects of AR signaling. Although CHD1 loss mainly impacts the expansion of the AR cistrome, loss of MAP3K7 drives increased AR target gene expression. Prostate cancer cell line models engineered to cosuppress MAP3K7 and CHD1 also demonstrated increased AR-v7 expression and resistance to the AR-targeting drug enzalutamide. Furthermore, we determined that low protein expression of both genes is significantly associated with biochemical recurrence (BCR) in a clinical cohort of radical prostatectomy specimens. Low MAP3K7 expression, however, was the strongest independent predictor for risk of BCR over all other tested clinicopathologic factors including CHD1 expression. Collectively, these findings illustrate the importance of MAP3K7 loss in a molecular subtype of prostate cancer that poses challenges to conventional therapeutic approaches. IMPLICATIONS: These findings strongly implicate MAP3K7 loss as a biomarker for aggressive prostate cancer with significant risk for recurrence that poses challenges for conventional androgen receptor-targeted therapies.
Published: 2021

3. Guided imagery for treatment (GIFT): protocol of a pilot trial of guided imagery versus treatment as usual to address radiotherapy-related distress in head and neck cancer

Author: Kolva, Elissa, Karam, Sana D., Carr, Alaina L., Roberts, Sydneyjane, Torkko, Kathleen, Lanning, Ryan, and Cox-Martin, Emily
Published: 2022
Full Text: View/download PDF

4. Unique macrophage phenotypes activated by BMP signaling in breast cancer bone metastases

Author: Ihle, Claire L., primary, Straign, Desiree M., additional, Canari, Johana A., additional, Torkko, Kathleen C., additional, Zolman, Kathryn L., additional, Smith, Elizabeth E., additional, and Owens, Philip, additional
Published: 2024
Full Text: View/download PDF

5. Interobserver Variation among Pathologists and Refinement of Criteria in Distinguishing Separate Primary Tumors from Intrapulmonary Metastases in Lung

Author: Nicholson, Andrew G., Torkko, Kathleen, Viola, Patrizia, Duhig, Edwina, Geisinger, Kim, Borczuk, Alain C., Hiroshima, Kenzo, Tsao, Ming S., Warth, Arne, Lantuejoul, Sylvie, Russell, Prudence A., Thunnissen, Erik, Marchevsky, Alberto, Mino-Kenudson, Mari, Beasley, Mary Beth, Botling, Johan, Dacic, Sanja, Yatabe, Yasushi, Noguchi, Masayuki, Travis, William D., Kerr, Keith, Hirsch, Fred R., Chirieac, Lucian R., Wistuba, Ignacio I., Moreira, Andre, Chung, Jin-Haeng, Chou, Teh Ying, Bubendorf, Lukas, Chen, Gang, Pelosi, Giuseppe, Poleri, Claudia, Detterbeck, Frank C., and Franklin, Wilbur A.
Published: 2018
Full Text: View/download PDF

6. Supplementary Figure S1 from Synergy between Androgen Receptor Antagonism and Inhibition of mTOR and HER2 in Breast Cancer

Author: Gordon, Michael A., primary, D'Amato, Nicholas C., primary, Gu, Haihua, primary, Babbs, Beatrice, primary, Wulfkuhle, Julia, primary, Petricoin, Emanuel F., primary, Gallagher, Isela, primary, Dong, Ting, primary, Torkko, Kathleen, primary, Liu, Bolin, primary, Elias, Anthony, primary, and Richer, Jennifer K., primary
Published: 2023
Full Text: View/download PDF

7. Data from Cooperative Dynamics of AR and ER Activity in Breast Cancer

Author: D'Amato, Nicholas C., primary, Gordon, Michael A., primary, Babbs, Beatrice, primary, Spoelstra, Nicole S., primary, Carson Butterfield, Kiel T., primary, Torkko, Kathleen C., primary, Phan, Vernon T., primary, Barton, Valerie N., primary, Rogers, Thomas J., primary, Sartorius, Carol A., primary, Elias, Anthony, primary, Gertz, Jason, primary, Jacobsen, Britta M., primary, and Richer, Jennifer K., primary
Published: 2023
Full Text: View/download PDF

8. Supplementary Table 1 from Synergy between Androgen Receptor Antagonism and Inhibition of mTOR and HER2 in Breast Cancer

Author: Gordon, Michael A., primary, D'Amato, Nicholas C., primary, Gu, Haihua, primary, Babbs, Beatrice, primary, Wulfkuhle, Julia, primary, Petricoin, Emanuel F., primary, Gallagher, Isela, primary, Dong, Ting, primary, Torkko, Kathleen, primary, Liu, Bolin, primary, Elias, Anthony, primary, and Richer, Jennifer K., primary
Published: 2023
Full Text: View/download PDF

9. Supplemental Figure 1 from A Role for Tryptophan-2,3-dioxygenase in CD8 T-cell Suppression and Evidence of Tryptophan Catabolism in Breast Cancer Patient Plasma

Author: Greene, Lisa I., primary, Bruno, Tullia C., primary, Christenson, Jessica L., primary, D'Alessandro, Angelo, primary, Culp-Hill, Rachel, primary, Torkko, Kathleen, primary, Borges, Virginia F., primary, Slansky, Jill E., primary, and Richer, Jennifer K., primary
Published: 2023
Full Text: View/download PDF

10. Supplementary Figure Legends from Synergy between Androgen Receptor Antagonism and Inhibition of mTOR and HER2 in Breast Cancer

Author: Gordon, Michael A., primary, D'Amato, Nicholas C., primary, Gu, Haihua, primary, Babbs, Beatrice, primary, Wulfkuhle, Julia, primary, Petricoin, Emanuel F., primary, Gallagher, Isela, primary, Dong, Ting, primary, Torkko, Kathleen, primary, Liu, Bolin, primary, Elias, Anthony, primary, and Richer, Jennifer K., primary
Published: 2023
Full Text: View/download PDF

11. Supplemental Figure Legends. from A Role for Tryptophan-2,3-dioxygenase in CD8 T-cell Suppression and Evidence of Tryptophan Catabolism in Breast Cancer Patient Plasma

Author: Greene, Lisa I., primary, Bruno, Tullia C., primary, Christenson, Jessica L., primary, D'Alessandro, Angelo, primary, Culp-Hill, Rachel, primary, Torkko, Kathleen, primary, Borges, Virginia F., primary, Slansky, Jill E., primary, and Richer, Jennifer K., primary
Published: 2023
Full Text: View/download PDF

12. Supplementary Table 1 from A Role for Tryptophan-2,3-dioxygenase in CD8 T-cell Suppression and Evidence of Tryptophan Catabolism in Breast Cancer Patient Plasma

Author: Greene, Lisa I., primary, Bruno, Tullia C., primary, Christenson, Jessica L., primary, D'Alessandro, Angelo, primary, Culp-Hill, Rachel, primary, Torkko, Kathleen, primary, Borges, Virginia F., primary, Slansky, Jill E., primary, and Richer, Jennifer K., primary
Published: 2023
Full Text: View/download PDF

13. Data from A Role for Tryptophan-2,3-dioxygenase in CD8 T-cell Suppression and Evidence of Tryptophan Catabolism in Breast Cancer Patient Plasma

Author: Greene, Lisa I., primary, Bruno, Tullia C., primary, Christenson, Jessica L., primary, D'Alessandro, Angelo, primary, Culp-Hill, Rachel, primary, Torkko, Kathleen, primary, Borges, Virginia F., primary, Slansky, Jill E., primary, and Richer, Jennifer K., primary
Published: 2023
Full Text: View/download PDF

14. Supplemental Figure 4 from A Role for Tryptophan-2,3-dioxygenase in CD8 T-cell Suppression and Evidence of Tryptophan Catabolism in Breast Cancer Patient Plasma

Author: Greene, Lisa I., primary, Bruno, Tullia C., primary, Christenson, Jessica L., primary, D'Alessandro, Angelo, primary, Culp-Hill, Rachel, primary, Torkko, Kathleen, primary, Borges, Virginia F., primary, Slansky, Jill E., primary, and Richer, Jennifer K., primary
Published: 2023
Full Text: View/download PDF

15. Supplementary Table S2 from Synergy between Androgen Receptor Antagonism and Inhibition of mTOR and HER2 in Breast Cancer

Author: Gordon, Michael A., primary, D'Amato, Nicholas C., primary, Gu, Haihua, primary, Babbs, Beatrice, primary, Wulfkuhle, Julia, primary, Petricoin, Emanuel F., primary, Gallagher, Isela, primary, Dong, Ting, primary, Torkko, Kathleen, primary, Liu, Bolin, primary, Elias, Anthony, primary, and Richer, Jennifer K., primary
Published: 2023
Full Text: View/download PDF

16. Data from Synergy between Androgen Receptor Antagonism and Inhibition of mTOR and HER2 in Breast Cancer

Author: Gordon, Michael A., primary, D'Amato, Nicholas C., primary, Gu, Haihua, primary, Babbs, Beatrice, primary, Wulfkuhle, Julia, primary, Petricoin, Emanuel F., primary, Gallagher, Isela, primary, Dong, Ting, primary, Torkko, Kathleen, primary, Liu, Bolin, primary, Elias, Anthony, primary, and Richer, Jennifer K., primary
Published: 2023
Full Text: View/download PDF

17. Data from Vitamin D Pathway and Other Related Polymorphisms and Risk of Prostate Cancer: Results from the Prostate Cancer Prevention Trial

Author: Torkko, Kathleen, primary, Till, Cathee, primary, Tangen, Catherine M., primary, Goodman, Phyllis J., primary, Song, Xiaoling, primary, Schenk, Jeannette M., primary, Lucia, M. Scott, primary, Peters, Ulrike, primary, van Bokhoven, Adrie, primary, Thompson, Ian M., primary, and Neuhouser, Marian L., primary
Published: 2023
Full Text: View/download PDF

18. Supplementary Methods from Cooperative Dynamics of AR and ER Activity in Breast Cancer

Author: D'Amato, Nicholas C., primary, Gordon, Michael A., primary, Babbs, Beatrice, primary, Spoelstra, Nicole S., primary, Carson Butterfield, Kiel T., primary, Torkko, Kathleen C., primary, Phan, Vernon T., primary, Barton, Valerie N., primary, Rogers, Thomas J., primary, Sartorius, Carol A., primary, Elias, Anthony, primary, Gertz, Jason, primary, Jacobsen, Britta M., primary, and Richer, Jennifer K., primary
Published: 2023
Full Text: View/download PDF

19. Supplementary Figure Legends from Cooperative Dynamics of AR and ER Activity in Breast Cancer

Author: D'Amato, Nicholas C., primary, Gordon, Michael A., primary, Babbs, Beatrice, primary, Spoelstra, Nicole S., primary, Carson Butterfield, Kiel T., primary, Torkko, Kathleen C., primary, Phan, Vernon T., primary, Barton, Valerie N., primary, Rogers, Thomas J., primary, Sartorius, Carol A., primary, Elias, Anthony, primary, Gertz, Jason, primary, Jacobsen, Britta M., primary, and Richer, Jennifer K., primary
Published: 2023
Full Text: View/download PDF

20. Supplemental Figure 3 from A Role for Tryptophan-2,3-dioxygenase in CD8 T-cell Suppression and Evidence of Tryptophan Catabolism in Breast Cancer Patient Plasma

Author: Greene, Lisa I., primary, Bruno, Tullia C., primary, Christenson, Jessica L., primary, D'Alessandro, Angelo, primary, Culp-Hill, Rachel, primary, Torkko, Kathleen, primary, Borges, Virginia F., primary, Slansky, Jill E., primary, and Richer, Jennifer K., primary
Published: 2023
Full Text: View/download PDF

21. Supplementary Tables 1-3 from Cooperative Dynamics of AR and ER Activity in Breast Cancer

Author: D'Amato, Nicholas C., primary, Gordon, Michael A., primary, Babbs, Beatrice, primary, Spoelstra, Nicole S., primary, Carson Butterfield, Kiel T., primary, Torkko, Kathleen C., primary, Phan, Vernon T., primary, Barton, Valerie N., primary, Rogers, Thomas J., primary, Sartorius, Carol A., primary, Elias, Anthony, primary, Gertz, Jason, primary, Jacobsen, Britta M., primary, and Richer, Jennifer K., primary
Published: 2023
Full Text: View/download PDF

22. Supplemental Figure 2 from A Role for Tryptophan-2,3-dioxygenase in CD8 T-cell Suppression and Evidence of Tryptophan Catabolism in Breast Cancer Patient Plasma

Author: Greene, Lisa I., primary, Bruno, Tullia C., primary, Christenson, Jessica L., primary, D'Alessandro, Angelo, primary, Culp-Hill, Rachel, primary, Torkko, Kathleen, primary, Borges, Virginia F., primary, Slansky, Jill E., primary, and Richer, Jennifer K., primary
Published: 2023
Full Text: View/download PDF

23. Supplementary Data from Vitamin D Pathway and Other Related Polymorphisms and Risk of Prostate Cancer: Results from the Prostate Cancer Prevention Trial

Author: Torkko, Kathleen, primary, Till, Cathee, primary, Tangen, Catherine M., primary, Goodman, Phyllis J., primary, Song, Xiaoling, primary, Schenk, Jeannette M., primary, Lucia, M. Scott, primary, Peters, Ulrike, primary, van Bokhoven, Adrie, primary, Thompson, Ian M., primary, and Neuhouser, Marian L., primary
Published: 2023
Full Text: View/download PDF

24. Supplementary Figures 1-6 from Cooperative Dynamics of AR and ER Activity in Breast Cancer

Author: D'Amato, Nicholas C., primary, Gordon, Michael A., primary, Babbs, Beatrice, primary, Spoelstra, Nicole S., primary, Carson Butterfield, Kiel T., primary, Torkko, Kathleen C., primary, Phan, Vernon T., primary, Barton, Valerie N., primary, Rogers, Thomas J., primary, Sartorius, Carol A., primary, Elias, Anthony, primary, Gertz, Jason, primary, Jacobsen, Britta M., primary, and Richer, Jennifer K., primary
Published: 2023
Full Text: View/download PDF

25. Supplemental Table 1 from Steroid Hormone Receptor and Infiltrating Immune Cell Status Reveals Therapeutic Vulnerabilities of ESR1-Mutant Breast Cancer

Author: Williams, Michelle M., primary, Spoelstra, Nicole S., primary, Arnesen, Spencer, primary, O'Neill, Kathleen I., primary, Christenson, Jessica L., primary, Reese, Jordan, primary, Torkko, Kathleen C., primary, Goodspeed, Andrew, primary, Rosas, Emmanuel, primary, Hanamura, Toru, primary, Sams, Sharon B., primary, Li, Zheqi, primary, Oesterreich, Steffi, primary, Riggins, Rebecca B., primary, Jacobsen, Britta M., primary, Elias, Anthony, primary, Gertz, Jason, primary, and Richer, Jennifer K., primary
Published: 2023
Full Text: View/download PDF

26. Supplemental Figures S1-S11 from Steroid Hormone Receptor and Infiltrating Immune Cell Status Reveals Therapeutic Vulnerabilities of ESR1-Mutant Breast Cancer

Author: Williams, Michelle M., primary, Spoelstra, Nicole S., primary, Arnesen, Spencer, primary, O'Neill, Kathleen I., primary, Christenson, Jessica L., primary, Reese, Jordan, primary, Torkko, Kathleen C., primary, Goodspeed, Andrew, primary, Rosas, Emmanuel, primary, Hanamura, Toru, primary, Sams, Sharon B., primary, Li, Zheqi, primary, Oesterreich, Steffi, primary, Riggins, Rebecca B., primary, Jacobsen, Britta M., primary, Elias, Anthony, primary, Gertz, Jason, primary, and Richer, Jennifer K., primary
Published: 2023
Full Text: View/download PDF

27. Supplementary Figure 1 from The HER4/4ICD Estrogen Receptor Coactivator and BH3-Only Protein Is an Effector of Tamoxifen-Induced Apoptosis

Author: Naresh, Anjali, primary, Thor, Ann D., primary, Edgerton, Susan M., primary, Torkko, Kathleen C., primary, Kumar, Rakesh, primary, and Jones, Frank E., primary
Published: 2023
Full Text: View/download PDF

28. Data from The HER4/4ICD Estrogen Receptor Coactivator and BH3-Only Protein Is an Effector of Tamoxifen-Induced Apoptosis

Author: Naresh, Anjali, primary, Thor, Ann D., primary, Edgerton, Susan M., primary, Torkko, Kathleen C., primary, Kumar, Rakesh, primary, and Jones, Frank E., primary
Published: 2023
Full Text: View/download PDF

29. 1448 Altered myeloid memory function by BMP signaling in breast cancer bone metastases

Author: Ihle, Claire, primary, Straign, Desiree, additional, Canari, Johana, additional, Torkko, Kathleen, additional, Zolman, Kathryn, additional, Smith, Erin, additional, and Owens, Philip, additional
Published: 2022
Full Text: View/download PDF

30. Prostatic atrophy: its spatial proximity to carcinoma and intraepithelial neoplasia based on annotation of digital slides

Author: Iczkowski, Kenneth A., Torkko, Kathleen C., Wilson, R. Storey, Lucia, M. Scott, and Bostwick, David G.
Published: 2014
Full Text: View/download PDF

31. Fascin Is Associated With Aggressive Behavior and Poor Outcome in Uterine Carcinosarcoma

Author: Richmond, Abby M., Blake, Erin A., Torkko, Kathleen, Smith, Elizabeth E., Spillman, Monique A., and Post, Miriam D.
Published: 2017
Full Text: View/download PDF

32. Active Surveillance is an Appropriate Management Strategy for a Proportion of Men Diagnosed with Prostate Cancer by Prostate Specific Antigen Testing

Author: Overholser, Stephen, Nielsen, Matthew, Torkko, Kathleen, Cwilka, Daniel, Weaver, Brandi, Shi, Xiaoyu, Leach, Robin J., Hernandez, Javier, Huang, Tim, Thompson, Ian M., Jr., and Thompson, Ian M., III
Published: 2015
Full Text: View/download PDF

33. Prostate Biopsy Markers of Inflammation are Associated with Risk of Clinical Progression of Benign Prostatic Hyperplasia: Findings from the MTOPS Study

Author: Torkko, Kathleen C., Wilson, Storey R., Smith, Elizabeth E., Kusek, John W., van Bokhoven, Adrie, and Lucia, Scott M.
Published: 2015
Full Text: View/download PDF

34. Reduced Expression of GDF-15 Is Associated With Atrophic Inflammatory Lesions of the Prostate

Author: Lambert, James R., Whitson, Ramon J., Iczkowski, Kenneth A., La Rosa, Francisco G., Smith, Maxwell L., Wilson, Storey R., Smith, Elizabeth E., Torkko, Kathleen C., Gari, Hamid H., and Lucia, Scott M.
Published: 2015
Full Text: View/download PDF

35. ZEB1 expression in type I vs type II endometrial cancers: a marker of aggressive disease

Author: Singh, Meenakshi, Spoelstra, Nicole S, Jean, Annie, Howe, Erin, Torkko, Kathleen C, Clark, Hilda R, Darling, Douglas S, Shroyer, Kenneth R, Horwitz, Kathryn B, Broaddus, Russell R, and Richer, Jennifer K
Published: 2008
Full Text: View/download PDF

36. Preoperative Prediction of Unifocal, Unilateral, Margin-Negative, and Small Volume Prostate Cancer

Author: Iczkowski, Kenneth A., Hossain, Deloar, Torkko, Kathleen C., Qian, Junqi, Lucia, M. Scott, Wheeler, Thomas M., Rewcastle, John C., and Bostwick, David G.
Published: 2008
Full Text: View/download PDF

37. p16INK4a is superior to high-risk human papillomavirus testing in cervical cytology for the prediction of underlying high-grade dysplasia

Author: Samarawardana, Panduka, Dehn, Donna L., Singh, Meenakshi, Franquemont, Douglas, Thompson, Chesney, Gaido, Loretta, Torkko, Kathleen C., Homer, Petra, Burke, Stephanie, Titmus, Matthew A., Nayi, Vipul, and Shroyer, Kenneth R.
Subjects: Cervical cancer -- Diagnosis, Cervical cancer -- Research, Cervix dysplasia -- Diagnosis, Cervix dysplasia -- Research, Cyclins -- Identification and classification, Cyclins -- Research, Predictive value of tests -- Research, Biological markers -- Identification and classification, Biological markers -- Research, Health
Published: 2010

38. Steroid Hormone Receptor and Infiltrating Immune Cell Status Reveals Therapeutic Vulnerabilities of ESR1-Mutant Breast Cancer

Author: Williams, Michelle M., primary, Spoelstra, Nicole S., additional, Arnesen, Spencer, additional, O'Neill, Kathleen I., additional, Christenson, Jessica L., additional, Reese, Jordan, additional, Torkko, Kathleen C., additional, Goodspeed, Andrew, additional, Rosas, Emmanuel, additional, Hanamura, Toru, additional, Sams, Sharon B., additional, Li, Zheqi, additional, Oesterreich, Steffi, additional, Riggins, Rebecca B., additional, Jacobsen, Britta M., additional, Elias, Anthony, additional, Gertz, Jason, additional, and Richer, Jennifer K., additional
Published: 2021
Full Text: View/download PDF

39. Human papillomavirus testing and molecular markers of cervical dysplasia and carcinoma

Author: Dehn, Donna, Torkko, Kathleen C., and Shroyer, Kenneth R.
Subjects: Papillomavirus infections -- Diagnosis, Tumor markers -- Analysis, Cervix dysplasia -- Diagnosis, Cytology -- Analysis, Health
Published: 2007

40. Steroid receptor coactivator AIB1 in endometrial carcinoma, hyperplasia and normal endometrium: correlation with clinicopathologic parameters and biomarkers

Author: Balmer, Nicole N, Richer, Jennifer K, Spoelstra, Nicole S, Torkko, Kathleen C, Lyle, Pamela L, and Singh, Meenakshi
Published: 2006
Full Text: View/download PDF

41. Guided Imagery for Treatment (GIFT): Protocol of a Pilot Trial of Guided Imagery Versus Treatment as Usual to Address Radiotherapy-related Distress in Head and Neck Cancer

Author: Kolva, Elissa, primary, Karam, Sana D, additional, Carr, Alaina, additional, Roberts, Sydneyjane, additional, Torkko, Kathleen, additional, Lanning, Ryan, additional, and Cox-Martin, Emily, additional
Published: 2020
Full Text: View/download PDF

42. Vitamin D Pathway and Other Related Polymorphisms and Risk of Prostate Cancer: Results from the Prostate Cancer Prevention Trial

Author: Torkko, Kathleen, primary, Till, Cathee, additional, Tangen, Catherine M., additional, Goodman, Phyllis J., additional, Song, Xiaoling, additional, Schenk, Jeannette M., additional, Lucia, M. Scott, additional, Peters, Ulrike, additional, van Bokhoven, Adrie, additional, Thompson, Ian M., additional, and Neuhouser, Marian L., additional
Published: 2020
Full Text: View/download PDF

43. B7-H4 expression in Brenner tumours, a descriptive and comparative study

Author: Yee, Eric U, Zaino, Richard J, Torkko, Kathleen C, and Shroyer, Kenneth R
Published: 2010
Full Text: View/download PDF

44. Association Between an Eestrogen Receptor Alpha Gene Polymorphism and the Risk of Prostate Cancer in Black Men

Author: Hernández, Javier, Balic, Ivana, Johnson-Pais, Teresa L., Higgins, Betsy A., Torkko, Kathleen C., Thompson, Ian M., and Leach, Robin J.
Published: 2006

45. Clinical staging of prostate cancer: a computer-simulated study of transperineal prostate biopsy

Author: CRAWFORD, E. DAVID, WILSON, SHANDRA S., TORKKO, KATHLEEN C., HIRANO, DAISAKU, STEWART, J. SCOTT, BRAMMELL, CRAIG, WILSON, R. STOREY, KAWATA, NOZOMU, SULLIVAN, HOLLY, LUCIA, M. SCOTT, and WERAHERA, PRIYA N.
Published: 2005

46. Inflammation as a Target for Prostate Cancer Chemoprevention: Pathological and Laboratory Rationale

Author: LUCIA, M. SCOTT and TORKKO, KATHLEEN C.
Published: 2004
Full Text: View/download PDF

47. Natural History of Prostate Cancer-Epidemiologic Considerations

Author: Miller, Gary J. and Torkko, Kathleen C.
Published: 2001

48. Testing for Chlamydia and Sexual History Taking in Adolescent Females: Results From a Statewide Survey of Colorado Primary Care Providers

Author: Torkko, Kathleen C., Gershman, Kenneth, Crane, Lori A., Hamman, Richard, and Barón, Anna
Published: 2000

49. Exosome proteomic analyses identify inflammatory phenotype and novel biomarkers in African American prostate cancer patients

Author: Panigrahi, Gati K., primary, Praharaj, Prakash P., additional, Kittaka, Hiroki, additional, Mridha, Asit R., additional, Black, Olen M., additional, Singh, Rakesh, additional, Mercer, Roger, additional, van Bokhoven, Adrie, additional, Torkko, Kathleen C., additional, Agarwal, Chapla, additional, Agarwal, Rajesh, additional, Abd Elmageed, Zakaria Y., additional, Yadav, Hariom, additional, Mishra, Santosh K., additional, and Deep, Gagan, additional
Published: 2019
Full Text: View/download PDF

50. A Role for Tryptophan-2,3-dioxygenase in CD8 T-cell Suppression and Evidence of Tryptophan Catabolism in Breast Cancer Patient Plasma

Author: Greene, Lisa I., primary, Bruno, Tullia C., additional, Christenson, Jessica L., additional, D'Alessandro, Angelo, additional, Culp-Hill, Rachel, additional, Torkko, Kathleen, additional, Borges, Virginia F., additional, Slansky, Jill E., additional, and Richer, Jennifer K., additional
Published: 2019
Full Text: View/download PDF

Catalog

Books, media, physical & digital resources

See catalog results

Searchworks

Select search scope, currently: Articles Catalog books, media & more in Jio Institute collections Articles journal articles & other e-resources

Search

Search Constraints

Refine your results

Search Limiters

Topic

Publication Year Range

Language

Publication Type

Journal

Database

Publisher

253 results on '"Torkko, Kathleen"'

Search Results

Catalog

Select search scope, currently: Articles

Catalog

books, media & more in Jio Institute collections

Articles

journal articles & other e-resources